Just days before the House plans to mark up its FDA user fee reauthorization bill, HHS Secretary Tom Price is pushing lawmakers to increase the fees payed by industry to cover 100 percent of medical product reviews, as proposed in President Donald Trump's skinny budget. The House Energy & Commerce health subcommittee will mark up its user fee reauthorization bill, the FDA Reauthorization Act of 2017 (FDARA), Thursday (May 18), subcommittee Chair Michael Burgess (R-TX) announced Tuesday (May 16). “To...